Hepatic Animations | Fusion Animation

3D MOD ANIMATION

NASH Pathophysiology

This Fusion Animation explores the Genetic Pathways in NASH progression. We detail key risk factors, including the PNPLA3 and TM6SF2 variants. Crucially, the animation focuses on HSD17B13, a promising therapeutic modulation target. We visualize how disease-protective variants suggest that reducing HSD17B13 expression can halt fibrosis. This showcases our expertise in Hepatology, Genetic Disease, and Drug Target MOA concepts.

3D MOD ANIMATION

NASH Pathophysiology

OUR CLIENTS

“We were really happy with the work and our collaboration with you. You really have a good team - all your different skills enabled the different projects to swiftly move forward with high satisfaction on our side. Thanks again!”

International Project Manager, OM Pharma

“The video is very high quality and we are very impressed... we are really happy with the animation, great work!”

Global Brand Manager, Unilever

“Thanks, it all looks great! Thanks to everyone on the team for your hard work.”

Senior Publishing Manager, Springer Nature

“The video looks really great!!! We really love it. We shared the video internally and there were many great comments. Thank you so much.”

Specialist, CDO Business Team, Samsung Biologics

Oncology

Immunology

Neurology

OUR CLIENTS

Do you have a burning question for us?